Add BrightSurf on Google Email

Bull ant evolves new way to target pain

Researchers at the University of Queensland discovered a venom molecule in bull ants that targets the echidna's pain pathway, potentially leading to new treatments for long-term pain. The molecule exploits an EGF signalling pathway, similar to those used in anti-cancer therapy.

SourceUniversity of Queensland·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 2, 2022

Venom factories: A surprising molecular convergence, from wasps to snakes

A study led by SIB Swiss Institute of Bioinformatics reveals a strong convergence in global gene expression levels of venom glands across diverse animals. The research found that different species, including fish, scorpions, and mammals, use similar molecular mechanisms to produce toxins.

SourceSwiss Institute of Bioinformatics·JournalProceedings of the National Academy of Sciences·TypeData/statistical analysis·DateJan 4, 2022

First genetic sequencing of Brazilian pit viper is completed

Researchers completed the first genetic sequencing of a Brazilian snake's genome, revealing that most toxin genes likely arose from existing functions in ancestral species. The study identified markers for comparing toxin genes with non-toxic 'ancestral' genes, shedding light on the evolution of venom production.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalProceedings of the National Academy of Sciences·DateAug 16, 2021

Repairing hearts with deadly spider venom

A drug candidate developed from a molecule in the venom of the Fraser Island funnel web spider can prevent damage caused by a heart attack and extend donor heart life for organ transplants. The treatment blocks a death signal sent from the heart after an attack, reducing cell death and improving survival.

SourceUniversity of Queensland·JournalCirculation·DateJul 16, 2021

Life-saving snake venom

A novel body tissue adhesive incorporating snake venom has been developed to stop life-threatening bleeding in seconds. The 'super glue' works with visible light and offers 10 times the strength of existing fibrin glue, cutting blood clotting time in half.

SourceUniversity of Western Ontario·JournalScience Advances·DateJul 15, 2021

Naturally abundant venom peptide from ants can activate a pseudo allergic pathway unravelling a novel immunomodulatory pathway of MRGPRX2

A research team has identified a naturally abundant venom peptide from ants that can initiate an immune response via a pseudo-allergic receptor MRGPRX2. The study reveals a novel pathway for this receptor, showing P17 induces infiltration of monocytes at the injected site by activating MRGPRX2.

SourceThe University of Hong Kong·JournalJournal of Allergy and Clinical Immunology·DateJul 12, 2021

Unusual prey: Spiders eating snakes

Researchers found that spiders from 11 different families can catch and eat snakes, including species up to one meter in length. The venom of these spiders also has a similar effect on snake nervous systems as it does on humans.

SourceUniversity of Basel·JournalJournal of Arachnology·DateJun 28, 2021

The very venomous caterpillar

A team of researchers from the University of Queensland has discovered a venomous caterpillar that produces peptides with high potency against nematode parasites and disease-causing pathogens. The study also unlocks a source of bioactive peptides with potential uses in medicine, biotechnology, and scientific tools.

SourceUniversity of Queensland·JournalProceedings of the National Academy of Sciences·DateJun 22, 2021

A mouse's bite holds venomous potential, finds new study

Researchers found that the genetic foundation required for oral venom to evolve is present in both reptiles and mammals. Salivary gland tissues in mammals display a similar pattern of gene activity as snake venom glands, suggesting an ancient functional core shared since the two lineages split hundreds of millions of years ago.

SourceOkinawa Institute of Science and Technology (OIST) Graduate University·JournalProceedings of the National Academy of Sciences·DateMar 29, 2021

Penn Medicine scientists engineer bacteria-killing molecules from wasp venom

Scientists at Penn Medicine have engineered bacteria-killing molecules from toxic proteins found in wasp venom, which could help combat antibiotic-resistant infections. The new antimicrobial molecules work by disrupting bacterial membranes and summoning immune cells, showing promise as potential treatments for sepsis and tuberculosis.

SourceUniversity of Pennsylvania School of Medicine·JournalProceedings of the National Academy of Sciences·DateOct 12, 2020

Snake venom evolved for prey not protection

A new study suggests that snake venom did not evolve primarily as a defense mechanism, but rather to overpower and kill prey. Researchers surveyed nearly 400 people who work with snakes and found that only a minority of bites cause immediate pain, implying that the venom's composition has not been optimized for defensive purposes.

SourceSwansea University·JournalToxins·DateMar 25, 2020

From cone snail venom to pain relief

Researchers have discovered a class of analgesics in conotoxin peptides, which are found in the venom of marine cone snails. These peptides show exceptional potency and selectivity for ion channels involved in pain transmission, offering new avenues for pain therapy.

SourceUniversity of Vienna·JournalChemical Reviews·DateNov 4, 2019